Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GLFD

Guilford (GLFD)

Guilford Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLFD
DateTimeSourceHeadlineSymbolCompany
09/29/20056:27PMPR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/01/20057:00AMBusiness WireMGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting PeriodNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200510:11AMPR Newswire (US)Guilford Pharmaceuticals Reports 2005 Second Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/20058:45AMPR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/02/20052:33PMPR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/24/20053:44PMPR Newswire (US)Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/18/20053:00PMPR Newswire (US)Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCONASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/17/20053:39PMPR Newswire (US)Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant GliomaNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/11/200511:01AMPR Newswire (US)AGGRASTAT(R) Injection Strategy Trial Data Published in JAMANASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/09/20059:42AMPR Newswire (US)Guilford Pharmaceuticals Reports 2005 First Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/09/20058:45AMPR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/02/20059:00AMPR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
04/21/20052:07PMPR Newswire (US)Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development ProgramNASDAQ:GLFDGuilford Pharmaceuticals (MM)
04/06/20058:45AMPR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
04/05/20051:31PMPR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/24/200512:04PMPR Newswire (US)Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary EndpointNASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/08/200511:03AMPR Newswire (US)Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/01/20053:55PMPR Newswire (US)Guilford Pharmaceuticals Reports 2004 Year-End Financial ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/01/20057:45AMPR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/10/200511:42AMPR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/17/20045:30PMPR Newswire (US)Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net ProceedsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/02/20048:45AMPR Newswire (US)Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) ProNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/22/20049:03AMPR Newswire (US)Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/17/20045:30PMPR Newswire (US)Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ RulesNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/17/20048:01AMPR Newswire (US)Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford PharmaceuticalsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/12/200410:58AMPR Newswire (US)AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/08/200412:11PMPR Newswire (US)Guilford Pharmaceuticals Reports 2004 Third Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/05/20048:30AMPR Newswire (US)Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004NASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/27/200410:33AMPR Newswire (US)Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends UntilNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/22/200410:03AMPR Newswire (US)Guilford to Present at UBS Global Life Sciences ConferenceNASDAQ:GLFDGuilford Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GLFD